While deletion of Srebf1 did not alter tumour load (Fig. S6i), deletion of Srebf2 resulted in a significant reduction in tumour burden in age matched KPLS2 compared to KPL mice (Fig. 6d, e). This evidence concerns the gene SREBF2 and neoplasm.